top of page


The role of dermocosmetics in the management of rosacea: an up-to-date
Over the past few years, the management of rosacea has undergone a significant evolution. While treatment was once focused almost exclusively on pharmacological therapies, growing evidence now highlights the fundamental role of dermocosmetics as an integral part of disease management, helping to restore skin barrier function, reduce inflammatory triggers, and improve long-term treatment adherence. This topic is the focus of the recently published mini-review "The Role of Derm


Facial Paralysis Treatment and Facial Symmetrization with Botulinum Neurotoxin: A Narrative Review with Illustrative Clinical Cases
Facial paralysis extends far beyond a clinical finding: it leads to static and dynamic asymmetry, hyperkinesis of the non-paralyzed side, and synkinesis, with significant consequences on quality of life, social interaction, and psychological well-being. Managing this condition requires a multidisciplinary approach and therapeutic tools capable of acting selectively and reversibly on the muscles involved. In this context, botulinum neurotoxin type A (BoNT-A) has established it


Ultrasound imaging in aesthetic medicine: safety and precision in injectable procedures
L’articolo analizza il ruolo dell’ecografia in medicina estetica, evidenziandone l’applicazione prima, durante e dopo le procedure iniettive. L’ecografia consente la visualizzazione in tempo reale delle strutture anatomiche e vascolari, migliorando la precisione, riducendo le complicanze e supportando trattamenti più mirati. Nonostante i numerosi vantaggi, il suo utilizzo è ancora limitato dalla mancanza di protocolli standardizzati e dalla necessità di una formazione specifi


Year 2025 - Research project funded by Agorà
RESEARCHER AND PROJECT Simone Lubrano Born in Livorno in 1985 Degree in Biological and Molecular Sciences, University of Pisa PhD in Molecular Medicine, University of Siena Project location Scuola Normale Superiore, Pisa Project objective To identify the molecular mechanisms underlying acquired resistance to targeted therapies in melanoma, with a particular focus on the interaction between the RAF/MEK and FAK signaling pathways, in order to develop pharmacological combination


Intravenous Anti-Aging Therapy with NAD⁺ and Glutathione: what does the scientific literature say?
This contribution is the result of the research work of Dr. Silvia Bianchi, member of the Agorà Anti-Aging Medicine Focus Group, and represents one of the first concrete outcomes of the group's shared scientific activity. The dossier presents a systematic review of the recent literature (2019–2024) on intravenous anti-aging therapy with NAD⁺ and glutathione, with the aim of providing an evidence-based overview for aesthetic physicians, endocrinologists and specialists in rege


The H.E.L.P. Project: When Aesthetic Medicine Becomes Integrated Care
A multidisciplinary preliminary report, currently undergoing peer review in an indexed scientific journal, systematically documents for the first time the impact of long-lasting aesthetic sequelae on patients' quality of life and psychological well-being. Authored by a group of contributors affiliated with Agorà — Italian Society of Aesthetic Medicine — alongside professionals in psychology and rehabilitative medicine, the work represents the first scientific publication of t


Dermcosmetics on television: Dr. Belmontesi guest on Milano Pavia TV
Dr. Belmontesi, coordinator of the Agorà Dermocosmesi Focus Group, carried out two medical-scientific outreach activities on the same day, both focused on dermocosmetics and collagen. During the morning, she participated as a speaker at the presentation of the Vichy Collagen Nutricosmetic at the Vichy medical division, bringing the Focus Group's scientific contribution on the topic of oral collagen supplementation and its synergy with topical dermocosmetics. In the evening, s


Peri-procedural dermocosmetic protocol combined with EBD (energy-based devices) treatment: literature review
Energy-based devices (fractional lasers, IPL, radiofrequency, HIFU, plasma) induce a controlled tissue inflammatory response that temporarily compromises the skin barrier function. Peri-procedural dermocosmetic management is not an optional add-on, but a therapeutic component with a direct impact on downtime, post-inflammatory hyperpigmentation (PIH) and long-term outcomes. Pre-procedural phase (2-6 weeks before) Skin preparation reduces the risk of complications and homogeni


Corporate Collaborations of the Dermocosmetics Focus Group
Event 1 | 23 April 2026 — Vichy Collagen Tour The event was designed as a medical-scientific educational session addressed to pharmacists, featuring an interview-based format that encouraged dynamic and direct interaction. Dr. Talerico’s presentation explored the topic of collagen from a holistic perspective, structured around four main thematic areas: Bioavailability and systemic absorption of hydrolyzed collagen peptides Indications and modalities of oral supplementation Qu


Commentary on Efficacy and Safety of Hyaluronic Acid Lip Fillers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Introduction Hyaluronic acid (HA) lip fillers represent one of the most widely performed procedures in aesthetic medicine today, with demand growing consistently over recent years. Despite broad clinical experience, perceptions of efficacy and safety have often been shaped by empirical observation rather than robust quantitative data. Against this backdrop, the systematic review and meta-analysis by Wen et al. carries particular significance: by analyzing exclusively randomiz


AGORÀ UP TO DATE 2026: Scientific Update and New Perspectives in Aesthetic Medicine
On April 11, 2026, at Monterosa 91 in Milan, Agorà Up To Date 2026 took place — a scientific update day dedicated to physician members of the Società Italiana di Medicina ad Indirizzo Estetico – Agorà, organized with the support of the Society's Focus Groups. The event provided an intensive educational forum integrating the latest scientific evidence with clinical experience sharing, interactive discussion, and real case presentations. The day opened with an institutional add


Ultrasound in Aesthetic Medicine: the First Joint Theoretical-Practical Course by Agorà and SIUMB
On April 13, 2026, at the Padova Convention Centre, the first joint Agorà–SIUMB course on ultrasound integration in aesthetic medicine practice was held. Theoretical sessions on anatomy, complication management and regulatory framework alternated with small-group hands-on training. This is the second module of a pathway leading to the Joint Agorà–SIUMB Diploma.


MILANO MARATHON 2026 – #OggiCorroPerAIRC
Anche nel 2026 Agorà ha partecipato alla Milano Marathon – Relay Marathon, unendo sport e responsabilità sociale. Sedici runner, divisi in quattro squadre, hanno corso a sostegno di AIRC – Fondazione per la Ricerca sul Cancro, trasformando l’attività fisica in un gesto concreto per la ricerca oncologica. Un’iniziativa che promuove salute, condivisione e impegno verso un obiettivo comune.


Year 2024 – FUV Research Project funded by Agorà
RESEARCHER AND PROJECT Emanuele Monteleone Born in Palermo in 1985 Degree in Cellular and Molecular Biology from the University of Turin PhD in Molecular Medicine from the University of Turin Project location University of Turin Project objective Molecular and clinical characterization of Extramammary Paget’s Disease: a project focused on a rare condition, with the aim of deepening the understanding of its molecular and clinical foundations and promoting increasingly targeted


Year 2023 - FUV Research Project funded by Agorà
RESEARCHER AND PROJECT Lishan Cui Born in Jilin, China in 1995 Graduated in Biological Sciences at the University of Camerino PhD in Molecular Biology and Cellular Biotechnology at the University of Camerino Project location Catholic University of the Sacred Heart, Rome Project objective To study the effect of plant extracellular vesicles in enhancing chemotherapy for the treatment of triple-negative breast cancer. PRESENTATION OF THE FINANCED PROJECT Also for 2023 Agorà ha


Year 2022 - FUV Research Project funded by Agorà
RESEARCHER AND PROJECT Fabrizio Fontana Master's Degree in Pharmaceutical Chemistry and Technology PhD in Integrative Biomedical Research University of Milan (MI) - Department of Pharmacological and Biomolecular Sciences Project location University of Milan Project objective Study the role of extracellular vesicles in the dialogue between ovarian tumor and tissue adipose tissue, clarifying the mechanisms of metastasis formation. PRESENTATION OF THE FINANCED PROJECT Also for


Year 2021 - FUV Research Project funded by Agorà
RESEARCHER AND PROJECT Uday Munagala Bachelor's Degree in Molecular Biology - University of Skovde (Sweden) PhD in Biomedical Sciences - University of Florence Project location National Research Center (CNR) - Pisa Project objective Develop new approaches to analyze circulating tumor DNA to improve the monitoring of breast cancer patients. PRESENTATION OF THE FINANCED PROJECT In 2021, during the Agorà Congress, Agorà decided, together with some partners, to support the Umbert


Agorà Scientific Committee Members at IMCAS 2026 Congress in Paris
The IMCAS Congress represents one of the leading international meetings dedicated to aesthetic medicine, dermatology, and plastic surgery, bringing together every year in Paris thousands of specialists from around the world to discuss the latest scientific and technological developments in the field. In 2026, numerous members of the Scientific Committee of Agorà – Italian Society of Aesthetic Medicine also attended the congress, contributing to the international scientific ex


Tattoos and laser removal: what does scientific evidence say?
What really happens in the dermis? One of the most relevant advances in recent scientific literature concerns the increasingly precise understanding of the biological dynamics of tattoo pigment. Contrary to the intuitive assumption that ink remains statically “deposited” in the skin, histological evidence demonstrates that tattoo pigment localizes within the dermis, where it is primarily engulfed by dermal macrophages and fibroblasts¹. This point is fundamental: tattoos do no


Commentary on the Article “Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies”
Commentary on the Article "Hyaluronic Acid Fillers and ASIA Syndrome: Case Studies” ASIA syndrome (Autoimmune/Inflammatory Syndrome Induced by Adjuvants), first described in 2011 by Professor Yehuda Schoenfeld, encompasses a group of clinical conditions in which the immune response is excessively modulated by substances with an adjuvant role—that is, molecules capable of enhancing the immune response without acting as direct antigens. These substances directly interfere with
bottom of page
